Andere talen Sirio Pharma Co., Ltd.

Aandelen

300791

CNE100003NB0

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
40,94 ^CNY	-0,15%		-2,66%	+18,12%

21/04	Sirio Pharma Co. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
2023	Sirio Pharma Co. Rapporteert winstresultaten voor de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	21/04
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	19/03
Sirio Pharma Co., Ltd.'s Equity Buyback announced on September 15, 2023, has closed with 1,285,600 shares, representing 0.71% for CNY 39.9 million.	18/03
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	02/01
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25-10-23
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2023.	25-09-23
Sirio Pharma Co., Ltd.(XSEC:300791) added to S&P Global BMI Index	18-09-23
Sirio Pharma Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	15-09-23
Sirio Pharma Co., Ltd. authorizes a Buyback Plan.	14-09-23
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24-08-23
Sirio Pharma Co., Ltd. Announces Implementation of Cash Dividend for the Year 2022, Payable on June 07, 2023	01-06-23
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27-04-23
Sirio Pharma Co., Ltd. Proposes Profit Distribution Proposal of Cash Dividend for the Year 2022	21-04-23
Sirio Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	20-04-23
Sirio Pharma Co., Ltd.(XSEC:300791) dropped from S&P Global BMI Index	19-12-22
Sirio Pharma Cancels Planned 1.35 Billion Yuan Share Sale to Fund Aquisition	09-12-22
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25-10-22
Sirio Pharma Co., Ltd. acquired 80% stake in Best Formulations Inc. from m Eugene C. Ung, Kelly C. Ung, Charles C. Ung, Peak Trust Company-NV, Jeffrey A. Goh, and Joy S. Hsu.	17-10-22
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2022.	25-09-22
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25-08-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Sirio Pharma Co., Ltd.

Aandelen

300791

CNE100003NB0

Andere talen

Filters